MEDINCELL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.66 EUR | +2.10% |
|
+14.05% | +75.83% |
| 17/04 | Medincell: share price rises following agreement with AbbVie | CF |
| 16/04 | Medincell, AbbVie to Co-Develop Injectable Therapeutics | DJ |
Chart calendar MedinCell S.A.
b056ef8d0c6824af35fe63c3eb.uZVFil2ZxqajH_8-R9Ue08T7PqnuVBkClZ4WilVjNJs.09ty0A3RocLLc7RvM7125oqzDcqfbXdq--llzDAsbdXV0C7JFP217cQstg~231b725a656c83c475ba26a336e8cec4
Upcoming events on MedinCell S.A.
Past events on MedinCell S.A.
| 11/04/2024 06:15 pm | Needham Healthcare Conference |
| 19/03/2024 01:30 am | UBS Virtual CNS Day |
| 29/02/2024 02:30 am | Evercore ISI Emerging Biotech Conference |
| 19/12/2023 11:00 pm | Q2 2024 Earnings Call |
| 19/12/2023 10:15 pm | Q2 2024 Earnings Release |
| 16/11/2023 07:00 pm | Jefferies London Healthcare Conference |
| 12/09/2023 09:30 pm | Annual General Meeting |
| 26/06/2023 10:00 pm | Q4 2023 Earnings Call |
| 26/06/2023 09:15 pm | Q4 2023 Earnings Release |
| 02/05/2023 11:00 pm | UZEDY™ FDA Approval Call |
| 18/04/2023 | ECCMID Meeting |
| 06/12/2022 11:00 pm | Interim 2023 Earnings Call |
| 06/12/2022 10:15 pm | Interim 2023 Earnings Release |
| 15/11/2022 | Jefferies London Healthcare Conference |
| 08/09/2022 | Extraordinary Shareholders Meeting |
| 14/06/2022 11:00 pm | FY 2022 Earnings Call |
| 14/06/2022 09:15 pm | FY 2022 Earnings Release |
| 09/12/2021 12:00 am | Interim 2022 Earnings Call |
| 08/12/2021 10:42 pm | Interim 2022 Earnings Release |
| 16/11/2021 | Jefferies London Healthcare Conference |
Annual results
| Fiscal Period | Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1,44 5,24 -72.48% | 2,85 2,88 -1.08% | 8,19 11,8 -30.73% | 4,09 7,44 -45.02% | 9,89 9,85 0.4% | 14,0 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -22,3 5,50 -505.38% | -22,4 -20,4 -9.88% | -18,8 |
|
EBIT Million EUR | Released Forecast Spread | -15,5 -13,7 -13.18% | -19,3 -20,1 3.83% | -15,4 -10,1 -52.32% | -23,8 -16,7 -43% | -24,0 -20,6 -16.63% | -19,9 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -19,7 -16,5 -19.19% | 0,00 0,00 - | 0,00 0,00 - | -24,8 -20,4 -21.71% | -32,0 -27,9 -14.73% | -21,3 |
|
Net income Million EUR | Released Forecast Spread | -19,7 -16,5 -19.05% | -23,9 -22,7 -5.49% | -19,0 -12,3 -54.2% | -24,8 -20,4 -21.71% | -29,5 -22,6 -30.71% | -23,6 |
|
EPS EUR | Released Forecast Spread | -1,14 -0,82 -39.02% | -1,19 -1,13 -5.31% | -0,86 -0,56 -53.57% | -1,00 -0,32 -217.46% | -1,27 -1,00 -27.42% | -0,91 |
| Announcement Date | 04/06/19 | 04/06/20 | 16/06/21 | 14/06/22 | 26/06/23 | - |
Quarterly results
| Fiscal Period | March | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 3,86 2,50 54.48% | 6,99 | 5,21 |
|
EBITDA Million EUR | Released Forecast Spread | -12,9 | -8,93 | |
|
EBIT Million EUR | Released Forecast Spread | -12,4 -13,6 9.02% | -9,81 | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -14,2 | ||
|
Net income Million EUR | Released Forecast Spread | -15,8 -14,7 -7.15% | -8,16 | -9,28 |
|
EPS EUR | Released Forecast Spread | -0,32 | ||
| Announcement Date | 26/06/23 | 19/12/23 | - |
More events
Past sector events for MedinCell S.A.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MEDCL Stock
- Calendar MedinCell S.A.
